In this study, we further characterized the immunostimulatory properties of this CpG-2722 and investigated its tumor-suppressive activities alone and in combination with anti-PD-1 using this developed orthotopic syngeneic HNSCC animal model. This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.